Suppr超能文献

镰状细胞病家系队列中胎儿血红蛋白、白细胞计数和其他临床特征的遗传力。

Heritability of fetal hemoglobin, white cell count, and other clinical traits from a sickle cell disease family cohort.

机构信息

Division of Hematology/Oncology, Boston Children's Hospital and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.

Broad Institute of MIT and Harvard, Cambridge, Massachusetts.

出版信息

Am J Hematol. 2019 May;94(5):522-527. doi: 10.1002/ajh.25421. Epub 2019 Feb 6.

Abstract

Sickle cell disease (SCD) is the most common monogenic disorder in the world. Notably, there is extensive clinical heterogeneity in SCD that cannot be fully accounted for by known factors, and in particular, the extent to which the phenotypic diversity of SCD can be explained by genetic variation has not been reliably quantified. Here, in a family-based cohort of 449 patients with SCD and 755 relatives, we first show that 5 known modifiers affect 11 adverse outcomes in SCD to varying degrees. We then utilize a restricted maximum likelihood procedure to estimate the heritability of 20 hematologic traits, including fetal hemoglobin (HbF) and white blood cell count (WBC), in the clinically relevant context of inheritance from healthy carriers to SCD patients. We report novel estimations of heritability for HbF at 31.6% (±5.4%) and WBC at 41.2% (±6.8%) in our cohort. Finally, we demonstrate shared genetic bases between HbF, WBC, and other hematologic traits, but surprisingly little overlap between HbF and WBC themselves. In total, our analyses show that HbF and WBC have significant heritable components among individuals with SCD and their relatives, demonstrating the value of using family-based studies to better understand modifiers of SCD.

摘要

镰状细胞病(SCD)是世界上最常见的单基因疾病。值得注意的是,SCD 存在广泛的临床异质性,无法用已知因素完全解释,特别是 SCD 的表型多样性在多大程度上可以用遗传变异来解释,这一点尚未得到可靠地量化。在这里,在一个由 449 名 SCD 患者和 755 名亲属组成的基于家庭的队列中,我们首先表明,5 个已知的修饰因子不同程度地影响 SCD 的 11 种不良结局。然后,我们利用受限最大似然程序来估计 20 种血液学特征的遗传力,包括胎儿血红蛋白(HbF)和白细胞计数(WBC),在从健康携带者到 SCD 患者的临床相关遗传背景下。我们报告了在我们的队列中 HbF 为 31.6%(±5.4%)和 WBC 为 41.2%(±6.8%)的新遗传力估计值。最后,我们证明了 HbF、WBC 和其他血液学特征之间存在共同的遗传基础,但令人惊讶的是,HbF 和 WBC 本身之间几乎没有重叠。总的来说,我们的分析表明,HbF 和 WBC 在 SCD 患者及其亲属中具有显著的遗传成分,这表明使用基于家庭的研究来更好地理解 SCD 的修饰因子具有价值。

相似文献

7
Discovering the genetics underlying foetal haemoglobin production in adults.发现成人胎儿血红蛋白产生的潜在遗传学机制。
Br J Haematol. 2009 May;145(4):455-67. doi: 10.1111/j.1365-2141.2009.07650.x. Epub 2008 Mar 2.
9
Fetal hemoglobin in sickle cell anemia.镰状细胞贫血中的胎儿血红蛋白。
Blood. 2011 Jul 7;118(1):19-27. doi: 10.1182/blood-2011-03-325258. Epub 2011 Apr 13.

本文引用的文献

2
Sickle Cell Disease.镰状细胞病
N Engl J Med. 2017 Apr 20;376(16):1561-1573. doi: 10.1056/NEJMra1510865.
6
Genetic modifiers of sickle cell disease.镰状细胞病的遗传修饰物。
Am J Hematol. 2012 Aug;87(8):795-803. doi: 10.1002/ajh.23232. Epub 2012 May 28.
8
Fetal hemoglobin in sickle cell anemia.镰状细胞贫血中的胎儿血红蛋白。
Blood. 2011 Jul 7;118(1):19-27. doi: 10.1182/blood-2011-03-325258. Epub 2011 Apr 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验